Digitalization of healthcare, Germany is taking the lead
A randomized controlled study: 61 patients with medium to advanced knee Osteoarthritis
re.flex Knee&Hip OA product was studied in a randomized control trial (RCT). 309 persons were assessed for eligibility. Patients were aged around 60 years old, suffering from medium or advanced knee or hip osteoarthritis. Finally we involved 61 patients: 31 to control group, 15 to study group A and study group AB. Study group A used the Sporlastic – re.flex smart rehabilitation brace, while group B exercised with the re.flex stand alone version.
Fig. 2 Eligibility criteria for the systematic review (PICOS-Scheme)
re.flex recorded a 90% overall adherence. More efficient in reducing pain than most common painkillers
The results from the Tubingen Study were very good and the positive health impact of the patients was significant. In terms of adherence, we’ve observed that in total, 75% of the training sessions were done and with an exercise repetition adherence of 90.25% and more.
This resulted in significant positive health outcomes for pain and physical function.
Fig. 3: With a blue line the results recorded by re.flex. With red the results of the current standard of care
Next steps: building more evidence for Hip Osteoarthritis and ACL post-surgery!
re.flex will continue the integration in Germany by exploring other areas such as Hip Osteoarthritis, in another trial set to be conducted by a team from Tubingen University.
A third research project will be conducted by a team from Charite University Hospital, in Berlin, and will involve patients recovering after an ACL reconstruction surgery.
Appreciating our content? Check out our Youtube channel